Northern Trust’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-75,255
| Closed | -$20K | – | 4747 |
|
|
2022
Q3 | $20K | Hold |
75,255
| – | – | ﹤0.01% | 4550 |
|
|
2022
Q2 | $58K | Sell |
75,255
-10
| -0% | -$9 | ﹤0.01% | 4370 |
|
|
2022
Q1 | $80K | Hold |
75,265
| – | – | ﹤0.01% | 4419 |
|
|
2021
Q4 | $143K | Sell |
75,265
-600
| -0.8% | -$1.44K | ﹤0.01% | 4312 |
|
|
2021
Q3 | $228K | Buy |
75,865
+600
| +0.8% | +$2.14K | ﹤0.01% | 4116 |
|
|
2021
Q2 | $294K | Sell |
75,265
-325,747
| -81% | -$1.35M | ﹤0.01% | 3947 |
|
|
2021
Q1 | $2.03M | Buy |
401,012
+138,129
| +53% | +$717K | ﹤0.01% | 3234 |
|
|
2020
Q4 | $1.07M | Buy |
262,883
+3,752
| +1% | +$18.4K | ﹤0.01% | 3488 |
|
|
2020
Q3 | $1.26M | Buy |
259,131
+171,668
| +196% | +$938K | ﹤0.01% | 3286 |
|
|
2020
Q2 | $485K | Buy |
87,463
+59,319
| +211% | +$272K | ﹤0.01% | 3558 |
|
|
2020
Q1 | $92K | Buy |
28,144
+7,571
| +37% | +$39.9K | ﹤0.01% | 3833 |
|
|
2019
Q4 | $93K | Hold |
20,573
| – | – | ﹤0.01% | 3949 |
|
|
2019
Q3 | $86K | Hold |
20,573
| – | – | ﹤0.01% | 3949 |
|
|
2019
Q2 | $78K | Hold |
20,573
| – | – | ﹤0.01% | 4010 |
|
|
2019
Q1 | $87K | Hold |
20,573
| – | – | ﹤0.01% | 3946 |
|
|
2018
Q4 | $51K | Hold |
20,573
| – | – | ﹤0.01% | 4046 |
|
|
2018
Q3 | $150K | Hold |
20,573
| – | – | ﹤0.01% | 3931 |
|
|
2018
Q2 | $77K | Hold |
20,573
| – | – | ﹤0.01% | 4057 |
|
|
2018
Q1 | $80K | Hold |
20,573
| – | – | ﹤0.01% | 4019 |
|
|
2017
Q4 | $75K | Sell |
20,573
-577
| -3% | -$2.18K | ﹤0.01% | 4026 |
|
|
2017
Q3 | $84K | Sell |
21,150
-80
| -0.4% | -$367 | ﹤0.01% | 3991 |
|
|
2017
Q2 | $108K | Sell |
21,230
-113,498
| -84% | -$637K | ﹤0.01% | 3964 |
|
|
2017
Q1 | $930K | Buy |
134,728
+1,717
| +1% | +$13.4K | ﹤0.01% | 3364 |
|
|
2016
Q4 | $1.24M | Sell |
133,011
-4,865
| -4% | -$43.8K | ﹤0.01% | 3290 |
|
|
2016
Q3 | $1.35M | Buy |
137,876
+4,623
| +3% | +$62.4K | ﹤0.01% | 3252 |
|
|
2016
Q2 | $1.88M | Buy |
133,253
+36,005
| +37% | +$562K | ﹤0.01% | 3069 |
|
|
2016
Q1 | $1.36M | Buy |
97,248
+5,993
| +7% | +$87.9K | ﹤0.01% | 3151 |
|
|
2015
Q4 | $1.86M | Buy |
91,255
+2,052
| +2% | +$31.7K | ﹤0.01% | 3100 |
|
|
2015
Q3 | $1.17M | Buy |
89,203
+29,054
| +48% | +$482K | ﹤0.01% | 3268 |
|
|
2015
Q2 | $923K | Buy |
60,149
+731
| +1% | +$14K | ﹤0.01% | 3376 |
|
|
2015
Q1 | $1.19M | Buy |
59,418
+2,188
| +4% | +$48.9K | ﹤0.01% | 3346 |
|
|
2014
Q4 | $1.2M | Sell |
57,230
-625
| -1% | -$12.7K | ﹤0.01% | 3332 |
|
|
2014
Q3 | $1.08M | Buy |
57,855
+45,382
| +364% | +$822K | ﹤0.01% | 3398 |
|
|
2014
Q2 | $288K | Buy |
+12,473
| New | +$220K | ﹤0.01% | 3748 |
|
Northern Trust's AGTC Position: Q4 2022 in Review
Northern Trust sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 75,255 shares — an estimated $20K sold.
Northern Trust first reported a position in AGTC in Q2 2014 and held it in 34 quarters. The position peaked at $2.03M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Northern Trust reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Northern Trust sold 75,255 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $20K.
- Northern Trust first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 34 quarters.
- Northern Trust's Applied Genetic Technologies Corporation position peaked at $2.03M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.